Products for Research Use Only

Scr-IN-1

CAT: 0804-HY-170958Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-170958Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Scr-IN-1 (Compound 4e) is a Tyrosine kinase inhibitor. Scr-IN-1 inhibits HCT-116 cells and MIA-PaCa-2 cells with IC50s of 0.16 μM and 1.16 μM, respectively. Scr-IN-1 displays selectivity profile on HCT-116 cells and MIA-PaCa-2 cells with SI > 625 and SI > 86, respectively. Scr-IN-1 induces Apoptosis in HCT-116 colon cancer cell and does not cause any change in the rate of necrotic cells. Scr-IN-1 is a novel SRC kinase inhibitor candidate for HCT-116 cells. Scr-IN-1 is potential for cancer research[1].
UNSPSC
12352005
Target
Apoptosis; Src
Related Pathways
Apoptosis; Protein Tyrosine Kinase/RTK
Field of Research
Cancer
Smiles
O=C1N(C(C2=CC=CC(Cl)=C2)=O)C3=C(C=C(OC(F)(F)F)C=C3)/C1=C\C4=CN(C)C5=C4C=CC=C5
Molecular Formula
C26H16ClF3N2O3
Molecular Weight
496.87
References & Citations
[1]Camcı-Eren M, et al. New 2-indolinone-indole hybrid compounds carrying a benzoyl moiety as tyrosine kinase inhibitors. Bioorg Chem. 2025 Mar;156:108203.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported